. .. Discussion,

I. , Evaluation de la mise en place des recommandations

I. I. Limites-de-l'étude and .. .. ,

C. .. ,

B. .. ,

A. .. ,

. , Annexe 1: Classification TNM (7ème édition), 2009.

. .. Au-chu-amienspicardie, Recommandations locales sur la prise en charge de l'anémie, vol.2

. , Grille de recueil, vol.3

S. F-h-société-française-d'hématologie, , 2017.

H. Ludwig, S. Van-belle, and P. Barrett-lee, The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients, Eur J Cancer, vol.40, issue.15, pp.2293-306, 2004.

E. Guardiola, F. Morschhauser, J. Zambrowski, and A. , Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment), Bull Cancer, vol.94, issue.10, pp.907-921, 2007.

J. E. Groopman and L. M. Itri, Chemotherapy-Induced Anemia in Adults: Incidence and Treatment, JNCI J Natl Cancer Inst, vol.91, pp.1616-1650, 1999.

S. Jefferies, B. Rajan, S. Ashley, D. Traish, and M. Brada, Haematological toxicity of cranio-spinal irradiation, Radiother Oncol, vol.48, issue.1, pp.23-30, 1998.
DOI : 10.1016/s0167-8140(98)00024-3

G. M. Rodgers, P. S. Becker, and M. Blinder, Cancer-and Chemotherapy-Induced Anemia, J Natl Compr Canc Netw, vol.10, issue.5, pp.628-53, 2012.
DOI : 10.6004/jnccn.2012.0064

URL : http://www.jnccn.org/content/10/5/628.full.pdf

I. Borget, P. Tilleul, M. Baud, A. Granghaud, E. Iglesias et al., A prospective study of quality of life and treatment of chemotherapy-induced anaemia in lung cancer, Rev Mal Respir, vol.24, issue.1, pp.41-48, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00597137

, Anémie et cancer-AFSOS

. Assoc and . Francoph, Soins Oncol. Support, 2017.

J. D. Rizzo, P. Hurley, and J. Seidenfeld, ASCO/ASH Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer, J Clin Oncol, vol.28, issue.33, pp.4996-5010, 2010.

M. S. Aapro and H. Link, update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents, The Oncologist, vol.13, issue.3, pp.33-39, 2007.
DOI : 10.1634/theoncologist.13-s3-33

URL : http://theoncologist.alphamedpress.org/content/13/suppl_3/33.full.pdf

L. T. Goodnough, E. Nemeth, and T. Ganz, Detection, evaluation, and management of iron-restricted erythropoiesis, Blood, vol.116, issue.23, pp.4754-61, 2010.
DOI : 10.1182/blood-2010-05-286260

URL : http://www.bloodjournal.org/content/116/23/4754.full.pdf

L. T. Goodnough, Iron deficiency syndromes and iron-restricted erythropoiesis (CME), vol.52, pp.1584-92, 2012.
DOI : 10.1111/j.1537-2995.2011.03495.x

M. Tonelli, B. Hemmelgarn, and T. Reiman, Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis, Can Med Assoc J, vol.180, issue.11, pp.62-71, 2009.

J. Bohlius, K. Schmidlin, and C. Brillant, Erythropoietin or Darbepoetin for patients with cancermeta-analysis based on individual patient data, Cochrane Database Syst Rev, issue.3, p.7303, 2009.
DOI : 10.1002/14651858.cd007303.pub2

URL : https://boris.unibe.ch/30199/1/Bohlius%20CochraneDatabaseSystRev%202009.pdf

. Epogen, , 2011.

J. Ferlay, I. Soerjomataram, and R. Dikshit, Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, vol.136, issue.5, pp.359-86, 2015.
DOI : 10.1002/ijc.29210

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.29210

, Les cancers en France en 2014-L'essentiel des faits et chiffres-Ref : ETKFRANCESYN15 | Institut National Du Cancer, 2017.

M. Grivaux, B. Duvert, and P. Ferrer-lopez, Amélioration de la survie à 1 an dans le cancer du poumon en France. Résultats des études prospectives en vie réelle, Rev Pneumol Clin, vol.72, issue.3, pp.163-70, 2016.
DOI : 10.1016/j.pneumo.2016.02.002

, Quelques chiffres-Cancer du poumon | Institut National Du Cancer, 2017.

D. Morgensztern, S. H. Ng, F. Gao, and R. Govindan, Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey, J Thorac Oncol, vol.5, issue.1, pp.29-33, 2010.

C. Locher, D. Debieuvre, and G. Leveiller, Le cancer bronchopulmonaire en France: quels changements en 10 ans ?, Lett Pneumol, vol.16, issue.5, pp.189-93, 2013.

C. Locher, L. Falchero, and C. Dujon, KBP-2010-CPHG: Characteristics and management of 6,083 new cases of non-small-cell-lung-cancer (NSCLC), Eur Respir J, vol.40, p.3128, 2012.

F. Vekeman, B. K. Bookhart, and J. White, Impact of limiting erythropoiesis-stimulating agent use for chemotherapy-induced anemia on the United States blood supply margin, Transfusion (Paris), vol.49, issue.5, pp.895-902, 2009.

H. Ludwig, M. Aapro, and C. Bokemeyer, Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study, Eur J Cancer Oxf Engl, vol.45, issue.9, pp.1603-1618, 1990.

J. Muñoz-langa, D. Castro, J. Gascó, and P. , Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study, Future Oncol Lond Engl, vol.11, issue.11, pp.1665-74, 2015.

A. Gafter-gvili, B. Rozen-zvi, and L. Vidal, Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia-systematic review and meta-analysis of randomised controlled trials, Acta Oncol, vol.52, issue.1, pp.18-29, 2012.

I. Gross, K. M. Trentino, A. Andreescu, R. Pierson, R. A. Maietta et al., Impact of a Patient Blood Management Program and an Outpatient Anemia Management Protocol on Red Cell Transfusions in Oncology Inpatients and Outpatients, The Oncologist, vol.21, issue.3, pp.327-359, 2016.

J. G. Aerts, A. Swieboda-sadlej, and C. Karanikiotis, Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study, Curr Med Res Opin, vol.28, issue.7, pp.1089-99, 2012.

M. D. Berger, B. Gerber, K. Arn, O. Senn, U. Schanz et al., Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantation, ANNEXES Annexe, vol.97, issue.1, pp.116-138, 2009.